JP2021509198A5 - - Google Patents

Download PDF

Info

Publication number
JP2021509198A5
JP2021509198A5 JP2020535175A JP2020535175A JP2021509198A5 JP 2021509198 A5 JP2021509198 A5 JP 2021509198A5 JP 2020535175 A JP2020535175 A JP 2020535175A JP 2020535175 A JP2020535175 A JP 2020535175A JP 2021509198 A5 JP2021509198 A5 JP 2021509198A5
Authority
JP
Japan
Prior art keywords
model
neuron
physiological
patient
ranges
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020535175A
Other languages
English (en)
Japanese (ja)
Other versions
JP7106646B2 (ja
JP2021509198A (ja
Filing date
Publication date
Priority claimed from US15/856,582 external-priority patent/US11227692B2/en
Application filed filed Critical
Publication of JP2021509198A publication Critical patent/JP2021509198A/ja
Publication of JP2021509198A5 publication Critical patent/JP2021509198A5/ja
Application granted granted Critical
Publication of JP7106646B2 publication Critical patent/JP7106646B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020535175A 2017-12-28 2018-12-06 個人化された薬剤処置のためのニューロン・モデルを生成するためのコンピュータ実施方法、コンピュータ・システム、およびコンピュータ・プログラム Active JP7106646B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/856,582 US11227692B2 (en) 2017-12-28 2017-12-28 Neuron model simulation
US15/856,582 2017-12-28
PCT/IB2018/059697 WO2019130135A1 (en) 2017-12-28 2018-12-06 Neuron model generation for personalised drug treatment

Publications (3)

Publication Number Publication Date
JP2021509198A JP2021509198A (ja) 2021-03-18
JP2021509198A5 true JP2021509198A5 (https=) 2021-04-30
JP7106646B2 JP7106646B2 (ja) 2022-07-26

Family

ID=67058418

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020535175A Active JP7106646B2 (ja) 2017-12-28 2018-12-06 個人化された薬剤処置のためのニューロン・モデルを生成するためのコンピュータ実施方法、コンピュータ・システム、およびコンピュータ・プログラム

Country Status (5)

Country Link
US (1) US11227692B2 (https=)
JP (1) JP7106646B2 (https=)
CN (1) CN111465852B (https=)
DE (1) DE112018006656T5 (https=)
WO (1) WO2019130135A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4038630A1 (en) * 2019-09-30 2022-08-10 F. Hoffmann-La Roche AG Means and methods for assessing huntington´s disease (hd)
CN112582069B (zh) * 2020-12-25 2023-01-17 南开大学 基于反应扩散模型的神经元树突棘发育模式建立方法
CN113161016A (zh) * 2020-12-31 2021-07-23 上海明品医学数据科技有限公司 一种智能医学服务系统、方法及存储介质
CN114358622B (zh) * 2022-01-07 2024-11-08 中创新航技术研究院(江苏)有限公司 工厂仿真方法及装置

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5121231A (en) * 1990-04-06 1992-06-09 University Of Southern California Incoherent/coherent multiplexed holographic recording for photonic interconnections and holographic optical elements
US5849995A (en) 1993-09-27 1998-12-15 The University Of British Columbia Mouse model for Huntington's Disease and related DNA sequences
AUPP398898A0 (en) 1998-06-09 1998-07-02 University Of Queensland, The Diagnostic method and apparatus
DE19832053A1 (de) * 1998-07-16 2000-01-27 Siemens Ag Verfahren zur Ermittlung des im Rahmen des Parkinson-Syndroms bzw. der Parkinson-Krankheit relevanten klinischen Zustands eines Patienten, sowie System hierfür
US6933147B2 (en) * 2000-08-17 2005-08-23 Icagen, Inc. Human cyclic nucleotide-gated channel polypeptide
US7461006B2 (en) 2001-08-29 2008-12-02 Victor Gogolak Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data
US8688385B2 (en) 2003-02-20 2014-04-01 Mayo Foundation For Medical Education And Research Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
US20040241720A1 (en) * 2003-02-26 2004-12-02 Salkoff Lawrence B. Sodium activated potassium ion channel for therapeutic drug screening
JP2007535959A (ja) * 2004-05-10 2007-12-13 エボテツク・ニユーロサイエンシーズ・ゲー・エム・ベー・ハー アルツハイマー病のためのｋｃｎｊ６の診断および治療使用
EP1802313B1 (en) * 2004-09-18 2010-11-03 University of Maryland, Baltimore Therapeutic agents trageting the ncca-atp channel and methods of use thereof
EP1839222A4 (en) * 2004-12-16 2010-01-13 Novascreen Biosciences METHOD OF IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF AGENTS MODULATING THE ACTIVITY OF AN ION CHANNEL
KR20070111475A (ko) * 2005-01-04 2007-11-21 노파르티스 아게 만성 변비 환자에서 테가세로드의 효능을 확인하기 위한바이오마커
CA2628108C (en) 2005-11-10 2020-01-07 Certara Usa, Inc. Method and apparatus for computer modeling the human brain for predicting drug effects
US7945392B2 (en) 2005-11-14 2011-05-17 Mclean Hospital Corporation Methods and systems for drug screening and computational modeling based on biologically realistic neurons
JP2009517186A (ja) 2005-11-29 2009-04-30 チルドレンズ ホスピタル メディカル センター 薬物選択及び投薬の最適化及び個別化
US20090306534A1 (en) * 2006-04-03 2009-12-10 President And Fellows Of Harvard College Systems and methods for predicting effectiveness in the treatment of psychiatric disorders, including depression
CN103424541B (zh) * 2006-05-18 2018-01-30 分子压型学会股份有限公司 确定针对病状的个性化医疗介入的系统和方法
EP3369827B1 (en) * 2008-03-12 2020-12-23 The Rockefeller University Methods and compositions for translational profiling and molecular phenotyping
JP2011523848A (ja) * 2008-05-21 2011-08-25 キネメッド， インコーポレイテッド 運動ニューロン疾患の調節物質を用いる処置方法および組成物
WO2009152485A2 (en) * 2008-06-13 2009-12-17 Ipierian, Inc. Methods of cell-based technologies
CN101658522B (zh) * 2008-08-26 2013-01-02 香港理工大学深圳研究院 他克林短链二聚体类化合物在制备治疗神经退行性疾病药物中的应用
WO2010111600A1 (en) * 2009-03-26 2010-09-30 The Ohio State University Research Foundation Polymorphism in cyp3a4 gene affecting drug metabolizing and uses thereof
CA2807949C (en) * 2010-08-13 2022-10-25 Intellimedicine, Inc. System and methods for the production of personalized drug products
WO2013030032A1 (en) * 2011-08-26 2013-03-07 F. Hoffmann-La Roche Ag A method for predicting clinical benefit in the treatment of neurodevelopmental, neurological or neuropsychiatric disorders
US20130262155A1 (en) 2012-04-03 2013-10-03 Thomas J. HinKamp System and method for collection and distibution of medical information
US9466024B2 (en) * 2013-03-15 2016-10-11 Northrop Grumman Systems Corporation Learning health systems and methods
JP2014239871A (ja) * 2013-05-07 2014-12-25 安東　秀夫 生体活動検出方法、生体活動測定装置、生体活動検出信号の転送方法および生体活動情報を利用したサービスの提供方法
US20140358512A1 (en) * 2013-06-03 2014-12-04 International Business Machines Corporation Automated construction of ion-channel models in a multi-comparment models
WO2015026135A1 (ko) * 2013-08-19 2015-02-26 서울대학교 산학협력단 약물 부작용 방지를 위한 개인별 단백질 손상 정보 기반의 약물 선택 방법 및 시스템
CA2933446A1 (en) * 2013-12-13 2015-06-18 The Governors Of The University Of Alberta Systems and methods of selecting compounds with reduced risk of cardiotoxicity
EP3134729A1 (en) * 2014-04-22 2017-03-01 Q-State Biosciences, Inc. Analysis of compounds for pain and sensory disorders
ES2787355T3 (es) * 2014-10-10 2020-10-15 Univ Freiburg Albert Ludwigs Biomateriales mejorados para implantes neuronales, y uso de dichos biomateriales en el diagnóstico y terapia de enfermedades neuronales
KR101617683B1 (ko) * 2015-01-09 2016-05-03 연세대학교 산학협력단 부정맥 치료제 효과 평가 시스템 및 방법
WO2017020015A2 (en) * 2015-07-29 2017-02-02 Atricure, Inc Ablation devices and methods of use
WO2017136285A1 (en) * 2016-02-01 2017-08-10 The Board Of Trustees Of The Leland Stanford Junior University Method and systems for analyzing functional imaging data
CN105998316B (zh) * 2016-05-23 2019-12-03 齐齐哈尔医学院 一种治疗老年性痴呆的中药组合物及其具体制备方法和相关应用
US10249389B2 (en) * 2017-05-12 2019-04-02 The Regents Of The University Of Michigan Individual and cohort pharmacological phenotype prediction platform
EP3723844B1 (en) * 2017-12-12 2023-08-09 Duke University Systems and methods for minimizing response variability of spinal cord stimulation

Similar Documents

Publication Publication Date Title
Vincent et al. With an eye on uncertainty: Modelling pupillary responses to environmental volatility
JP2021509198A5 (https=)
De Jong et al. Variation in hospital length of stay: do physicians adapt their length of stay decisions to what is usual in the hospital where they work?
Bair et al. Multivariable modeling of phenotypic risk factors for first-onset TMD: the OPPERA prospective cohort study
WO2020220545A1 (zh) 基于长短期记忆模型的疾病预测方法、装置和计算机设备
JP2013524355A5 (https=)
JP2017523841A5 (https=)
JP2018507470A (ja) 高悪性度膀胱癌の化学療法に対する奏効を予測するシステムおよび方法
Tasnim et al. Investigating personalization techniques for improved cybersickness prediction in virtual reality environments
Niles et al. Advancing personalized medicine: application of a novel statistical method to identify treatment moderators in the coordinated anxiety learning and management study
JP7634464B2 (ja) 介入効果分析システム、及び介入効果分析方法
Stewart et al. Implications of process error in selectivity for approaches to weighting compositional data in fisheries stock assessments
JPWO2021245733A5 (ja) 脳画像解析装置、制御方法、及びプログラム
Ye et al. The President’s Malaria Initiative contributed to reducing malaria burden in sub-Saharan Africa between 2004 and 2014: Evidence from generalized estimating equation analysis
TWI774964B (zh) 患病機率預測方法與電子裝置
KR20240146701A (ko) Xr 인터랙션 사용자의 가상 태스크 수행 효율성 분석 장치 및 방법
Ofir‐Geva et al. Use of multi‐perturbation Shapley analysis in lesion studies of functional networks: The case of upper limb paresis
KR20230037432A (ko) 사용자의 치매 정도 결정 방법 및 장치
KR102127449B1 (ko) 생존율 예측 모델 생성 방법, 장치 및 컴퓨터 프로그램
Ricard et al. Validation of models for analysis of ranks in horse breeding evaluation
CN118675689A (zh) 一种基于下肢康复器械的康复方案生成方法和装置
Finch Recursive partitioning in the presence of multilevel data
WO2015173917A1 (ja) 分析システム
WO2023072513A1 (en) Contextualizing the analysis of medical images
GB2583309A (en) Neuron model generation for personalised drug treatment